Healthcare - Biotechnology - NASDAQ - GB
$ 2.08
-7.56 %
$ 25.3 M
Market Cap
-0.7
P/E
CASH FLOW STATEMENT
-16.4 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
7.02 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Akari Therapeutics, Plc
| Net Income | -10 M |
| Depreciation & Amortization | 4 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 1.15 M |
| Change in Working Capital | 70 K |
| Others | -7.58 M |
| Free Cash Flow | -16.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | (10.0) | (17.7) | (17.4) | (20.5) | (24.8) | (23.5) | (35.4) | (18.1) | (45.3) | (9.6) | (3.6) | (4.3) | (2.1) | (0.7) |
| Depreciation & Amortization | 4 K | 3.71 K | 4.13 K | 8 K | 18 K | 39 K | 42.4 K | 39.9 K | 10.2 K | 8 K | 2 K | 2 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 2.9 | 3.0 | 0 | (2.5) | 3 | (11.4) | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.1 | 0.7 | 0.3 | 0.3 | 1.0 | 1.6 | 2.7 | 3.9 | 1.8 | 0.5 | 94 K | 0.5 | 0.1 | 0 |
| Other Operating Activities | (7.6) | (5.3) | 0.2 | 3.2 | 0.2 | (0.1) | 2.7 | (9.0) | 45.3 | (0.6) | (0.3) | (0.4) | (0.1) | 95 K |
| Change in Working Capital | 70 K | 0.8 | (2.0) | (2.9) | 8.3 | (0.6) | 0.8 | (1.5) | 4.7 | 0.3 | (1.6) | 2.0 | 1.1 | 0.4 |
| Cash From Operations | (16.4) | (21.5) | (18.8) | (17.0) | (12.3) | (22.5) | (31.6) | (24.6) | (5.0) | (9.5) | (5.5) | (2.1) | (1.0) | (0.4) |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 36.9 K | 54.8 K | 10.6 K | 57 K | 0 | 4 K | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 10.0 | (10.0) | 1.4 | (0.1) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 10.0 | (10.1) | 1.4 | (0.2) | 0 | 4 K | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 | (1.1) | 0.9 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.0 | 94 K | 0 | 27.5 K | 0 | (0.2) | 0 | 0 | (6.0) | 4.1 | 0 | 0 | 0 | 0 |
| Cash From Financing Activities | 7.0 | 25.3 | 14.3 | 25.1 | 12.0 | 0.3 | 15.7 | 0 | 69.0 | 8.2 | 12.0 | 3.2 | 1.0 | 0.4 |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | (9.4) | 3.9 | (4.7) | 8.3 | (0.2) | (22.3) | (6.0) | (34.8) | 65.6 | (1.4) | 6.6 | 1.1 | 3 K | 6 K |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | (16.4) | (21.5) | (18.8) | (17.0) | (12.3) | (22.5) | (31.6) | (24.7) | (5.0) | (9.5) | (5.5) | (2.1) | (1.0) | (0.4) |